Introduction to economic modeling for clinical rheumatologists: application to biologic agents in rheumatoid arthritis

Author： Marra Carlo   Bansback Nick   Anis Aslam   Shojania Kamran  

Publisher： Springer Publishing Company

ISSN： 0770-3198

Source： Clinical Rheumatology, Vol.30, Iss.1, 2011-03, pp. : 9-18

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Depression is improved when low-dose tacrolimus is given to rheumatoid arthritis patients showing an inadequate response to biologic agents

By Miwa Yusuke   Hosaka Michio   Ohtsuka Kumiko   Sato Michihito   Takahashi Ryo   Wakabayashi Kuninobu   Odai Tsuyoshi   Yajima Nobuyuki   Kasama Tsuyoshi  

Modern Rheumatology, Vol. 23, Iss. 5, 2013-09 ,pp. : 920-924

Springer Publishing Company

Access to resources Recommend Favorite

Update on Targets of Biologic Therapies for Rheumatoid Arthritis

By  

Current Rheumatology Reviews, Vol. 4, Iss. 4, 2008-11 ,pp. : 246-253

Bentham Science Publishers

Access to resources Recommend Favorite

Integrated neuroendocrine immune risk factors in relation to rheumatoid arthritis: should rheumatologists now adopt a model of a multiyear, presymptomatic phase?

By Masi A. T.   Aldag J. C.  

Scandinavian Journal of Rheumatology, Vol. 34, Iss. 5, 2005-10 ,pp. : 342-352

Informa Healthcare

Access to resources Recommend Favorite

Using the new biologic therapies in rheumatoid arthritis: practical aspects

By Markenson Joseph A  

Future Rheumatology, Vol. 2, Iss. 5, 2007-10 ,pp. : 475-483

Future Medicine

Access to resources Recommend Favorite

A biologic pharmacosurveillance program for rheumatoid arthritis: a single-center experience

By Russell Anthony  

Clinical Rheumatology, Vol. 32, Iss. 6, 2013-06 ,pp. : 875-877

Springer Publishing Company

Access to resources Recommend Favorite